Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Meta Platforms
META
Adobe
ADBE
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 34.080
- -0.040-0.12%
Close Dec 27 16:00 ET
- 34.080
- 0.0000.00%
Post 19:37 ET
69.53BMarket Cap22.41P/E (TTM)
34.170High33.870Low3.17MVolume33.970Open34.120Pre Close108.06MTurnover0.16%Turnover Ratio11.34P/E (Static)2.04BShares44.84752wk High3.96P/B67.32BFloat Cap32.82552wk Low1.60Dividend TTM1.98BShs Float44.847Historical High4.69%Div YieldTTM0.88%Amplitude6.373Historical Low34.042Avg Price1Lot Size
GlaxoSmithKline News
6-K: Gsk on track to deliver 2024 outlooks with further good progress made in r&d
6-K: Gsk Delivers Continued Strong Performance and Upgrades 2024 Guidance
6-K: Gsk Makes a Strong Start to 2024 with Improving Outlook for the Year
GlaxoSmithKline | 6-K: Glaxosmithkline 2023 Annual Report on Form 20-F
GlaxoSmithKline | 20-F: FY2023 Annual Report
GlaxoSmithKline | 6-K: Gsk Delivers Strong 2023 Performance and Upgrades Growth Outlooks
GlaxoSmithKline | 6-K: Strong Year-to-Date and Q3 Performance Drives Upgrade to Full-Year Guidance
GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)
GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)
GlaxoSmithKline | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)
GlaxoSmithKline | 20-F: FY2022 Annual Report
GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)
GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)
GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)
GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)
GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)
GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)
GlaxoSmithKline | 20-F: FY2021 Annual Report
GlaxoSmithKline | 6-K: Report of foreign private issuer (related to financial reporting)
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
